You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 96 No. 2, February 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Experimental retinal vascular occlusion. I. Pathogenesis of central retinal vein occlusion

S. S. Hayreh, W. A. van Heuven and M. S. Hayreh

In 45 eyes of rhesus monkeys, five types of central retinal vascular occlusion were produced by lateral orbitotomy: group 1, central retinal vein occlusion (CRVO) alone; group 2, CRVO with simultaneous central retinal artery (CRA) occlusion; group 3, CRVO with transient clamping of the CRA for either 2 to 2 1/2 hours (group 3A) or 6 to 7 1/2 hours (group 3B); and group 4, CRVO with segmental retinal ischemia. The eyes were examined by fundus photography and fluorescein angiography for up to nine months. Group 1 developed venous stasis retinopathy (VSR) and group 3B hemorrhagic retinopathy (HR). In group 4 the ischemic and nonischemic segments of the retina developed segmental HR and VSR, respectively. Groups 2 and 3A developed neither VSR nor HR. Retinal capillary obliteration occurred in groups 2 and 3B and in the ischemic part of group 4, starting one to three weeks after the occlusion and progressing thereafter. These studies indicate that clinically co-called CRVO consists of two distinct entities: VSR and HR, with retinal ischemia playing an important role in the production of HR. On the basis of the present and other available information, the pathogenesis of CRVO was concluded to be multifactorial.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibition of Ocular Angiogenesis by an Adenovirus Carrying the Human von Hippel-Lindau Tumor-Suppressor Gene In Vivo
Akiyama et al.
IOVS 2004;45:1289-1296.
ABSTRACT | FULL TEXT  

A pilot study of pars plana vitrectomy, intraocular gas, and radial neurotomy in ischaemic central retinal vein occlusion
Williamson et al.
Br. J. Ophthalmol. 2003;87:1126-1129.
ABSTRACT | FULL TEXT  

Pattern of Vascular Nonperfusion in Retinal Venous Occlusions Occurring Within the Optic Nerve With and Without Optic Nerve Head Swelling
Beaumont and Kang
Arch Ophthalmol 2000;118:1357-1363.
ABSTRACT | FULL TEXT  

Superselective Ophthalmic Arterial Fibrinolysis with Urokinase for Recent Severe Central Retinal Venous Occlusion: Initial Experience
Vallée et al.
Radiology 2000;216:47-53.
ABSTRACT | FULL TEXT  

Arterial blood flow characteristics in central retinal vein occlusion and effects of panretinal photocoagulation treatment: an investigation by colour Doppler imaging
Avunduk et al.
Br. J. Ophthalmol. 1999;83:50-53.
ABSTRACT | FULL TEXT  

Central retinal vein occlusion: what's the story?
WILLIAMSON
Br. J. Ophthalmol. 1997;81:698-704.
FULL TEXT  

Combined Central Retinal Arterial and Venous Obstruction: Emergency Ophthalmic Arterial Fibrinolysis
Vallee et al.
Radiology 2002;223:351-359.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.